Concepedia

Publication | Open Access

AR420626, a selective agonist of GPR41/FFA3, suppresses growth of hepatocellular carcinoma cells by inducing apoptosis <i>via</i> HDAC inhibition

41

Citations

26

References

2020

Year

Abstract

AR420626, a selective GPR41/FFA3 agonist, may be a candidate as a therapeutic agent for HCC.

References

YearCitations

Page 1